Hikma Pharmaceuticals and Vectura codevelopment and commercialization of GSK’s Breo Ellipta generics
Hikma Pharmaceuticals and Vectura have signed a deal to develop and market generic versions of GlaxoSmithKline’s Ellipta portfolio, utilising the latter’s Open-Inhale-Close... Read More
Case Study: USFDA approval of GSK’s Trelegy Ellipta – Triple Drug for COPD
Posted on20 Sep 2017
Comments0
GSK has won US approval for its triple-therapy inhaler for chronic obstructive pulmonary disease. Brand Name: Trelegy Ellipta Type: Triple Drug Combination... Read More